Radioligand therapy in prostate cancer
- Interview
Dr. Silke GillessenUniv. of Manchester / The Christie

The APCCC chairs break down the congress’s radioligand session and the debates heading to APCCC 2026 in Lugano.
- Type
- Interview
- Published
- Topic
- Genitourinary







-e6d6a8d836.png&w=3840&q=75)
